Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios

Keyphrases

• Atrial Fibrillation 100%
• Oral Anticoagulants 100%
• Stroke Prevention in Atrial Fibrillation 100%
• Anticoagulant Use 100%
• Stroke Prevention 50%
• Patient Characteristics 25%
• Dementia 25%
• Myocardial Infarction 25%
• Arrhythmia 25%
• Low Dose Rate 25%
• Increasing Prevalence 25%
• Sudden Cardiac Death 25%
• Ischemic Stroke 25%
• Warfarin 25%
• Non-vitamin K Antagonist Oral Anticoagulants 25%
• Major Bleeding 25%
• Risk of Ischemic Stroke 25%
• Vitamin K Antagonists 25%
• Dabigatran 25%
• Apixaban 25%
• Edoxaban 25%
• Rivaroxaban 25%

Medicine and Dentistry

• Apoplexy 100%
• Atrial Fibrillation 100%
• Antithrombotic 100%
• Brain Ischemia 40%
• Vitamin K Antagonist 40%
• Prevalence 20%
• Myocardial Infarction 20%
• Cardiac Dysrhythmia 20%
• Sudden Cardiac Death 20%
• Prothrombin 20%
• Patient Characteristics 20%
• Congestive Heart Failure 20%
• Warfarin 20%
• Major Bleeding 20%
• Dabigatran 20%
• Edoxaban 20%
• Apixaban 20%
• Rivaroxaban 20%
• Factor VII 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Cerebrovascular Accident 100%
• Anticoagulant Agent 100%
• Atrial Fibrillation 100%
• Brain Ischemia 40%
• Antivitamin K 40%
• Prevalence 20%
• Heart Arrhythmia 20%
• Heart Infarction 20%
• Congestive Heart Failure 20%
• Sudden Cardiac Death 20%
• Bleeding 20%
• Prothrombin 20%
• Blood Clotting Factor 10 20%
• Warfarin 20%
• Rivaroxaban 20%
• Dabigatran 20%
• Apixaban 20%
• Edoxaban 20%